ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Noxafil 100 mg, magensaftresistente Tablette - 24 Tablette(n)
63240001 MSD Merck Sharp & Dohme AG
Noxafil 100 mg, magensaftresistente Tablette18.02.2015
Original18.02.2015
Posaconazole (J02AC04) 
WHO-DDD 
08.06.24 Tablette(n)
08.06. 
B  
Yes 
IPCI
617.34Yes
    
10 %684.35
7680632400015Synthetika
6303658 
Composition
posaconazolum 100 mg, hypromellosi acetas succinas, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis hydrica, carmellosum natricum conexum corresp. natrium 2.29 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (flavum), pro compresso obducto.
Packungsbestandteile
Gastric juice resistant tablets 
 
Active AgentDose
Posaconazole100 mg
BAG: Active AgentDose
Posaconazole100 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Hydroxypropylcellulosum  
Hypromellosi Acetas Succinas  
Macrogol3350  
Magnesii Stearas  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Silica Colloidalis Hydrica  
Talcum  
 
Source
Data was imported : 05.04.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home